Ryan Spencer - 26 Apr 2024 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Director
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
26 Apr 2024
Net transactions value
$0
Form type
4
Filing time
30 Apr 2024, 16:11:30 UTC
Previous filing
30 Apr 2024
Next filing
19 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Stock Option (right to buy) Award $0 +4,250 $0.000000 4,250 26 Apr 2024 Common Stock 4,250 $12.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3rd of the total number of shares subject to the award shall vest on April 26, 2025 and the remaining 2/3rds of the shares will vest in equal monthly installments over a two year period such that the option is fully vested on April 26, 2027.